Medicine and Dentistry
Prostate Cancer
100%
Inpatient
62%
Bone Metastasis
55%
Ankle Brachial Index
50%
Woman
50%
Oral Contraceptive Agent
50%
Bone Scintigraphy
50%
Toe
50%
Glucose Uptake
50%
Fluorine-18
50%
Lymph Node Metastasis
50%
Deoxyglucose
50%
Systematic Review
50%
Exercise Test
50%
Treadmill Exercise
50%
Aptitude
50%
Diagnostics
50%
Patient
40%
Meta-Analysis
20%
Diagnostic Performance
20%
Diagnosis
17%
Blood Clotting
15%
Arteriosclerosis Obliterans
14%
Limb
14%
Chronic Kidney Disease
12%
Lesion
12%
Positron Emission Tomography-Computed Tomography
12%
Lymphoma
12%
Association
11%
Bone
10%
Patient with Cancer
10%
Complement Component C1s Inhibitor
10%
Coagulation Factor XII
10%
Diagnostic Accuracy
10%
Prevalence
10%
Observation
10%
Claudication
7%
Follow up
5%
Blood Sampling
5%
Coagulation
5%
Blood Proteins
5%
Serositis
5%
Study Subject
5%
Factor XII
5%
Venous Thromboembolism
5%
Fibrinolysis
5%
Plasma
5%
Measurement
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Clinical Trial
90%
Bone Metastasis
55%
Oral Contraceptive Agent
50%
Kininogen
15%
Kallikrein
10%
Prekallikrein
10%
Blood Clotting Factor 12
10%
Prevalence
10%
Complement Component C1s Inhibitor
10%
Thrombus
5%
Venous Thromboembolism
5%
Blood Clotting Factor
5%
Plasma Protein
5%
Inflammation
5%
Biochemistry, Genetics and Molecular Biology
Taxonomy
50%
Bone
50%
Staging
50%
Electric Potential
15%
Coagulation System
15%
Kininogen
15%
Association
11%
Kallikrein
10%
Prekallikrein
10%
Data Base
5%
Sample
5%
Blood Level
5%
Surface Property
5%
Fibrinolysis
5%
Plasma Protein
5%
Coagulation
5%
Factor XII
5%
